Low dose cadmium treatment is accompanied by an increase in VEGF and upregulation of MAPK (p38, ERK and JNK) pathways [189], and the role of VEGF in human coronary atherosclerosis is well established [190]. The gene discussed is VEGFA; the disease is coronary atherosclerosis.